(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation-Reference-Cited by-同舟云学术

(Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation

Published:2012-04-25 Issue:7 Volume:25 Page:723-731
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:

Author:

Höcker Britta,Böhm Stephan,Fickenscher Helmut,Küsters Uta,Schnitzler Paul,Pohl Martin,John Ulrike,Kemper Markus J.,Fehrenbach Henry,Wigger Marianne,Holder Martin,Schröder Monika,Feneberg Reinhard,Köpf-Shakib Sabine,Tönshoff Burkhard

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1432-2277.2012.01485.x/fullpdf

Reference32 articles.

1. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children;Ho;Transplantation,1988

2. Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation;Smith;J Am Soc Nephrol,2010

3. The role of EBV in post-transplant malignancies: a review;Hopwood;J Clin Pathol,2000

4. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma;Opelz;Transplantation,2009

5. Risk factors for early-onset and lateonset post-transplant lymphoproliferative disorder in kidney recipients in the United States;Quinlan;Am J Hematol,2011

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Epstein-Barr Virus infection in immunocompromised patients;Biochemical Pharmacology;2024-07

2. A Focused Review of Epstein-Barr Virus Infections and PTLD in Pediatric Transplant Recipients: Guidance From the IPTA and ECIL Guidelines;Journal of the Pediatric Infectious Diseases Society;2024-02-01

3. Post-Transplant Lymphoproliferative Disorders;Seminars in Nephrology;2024-01

4. Antiviral Agents: Ganciclovir/Valganciclovir;Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century;2024

5. Viruses and Carcinogenesis;Reference Module in Biomedical Sciences;2024